Re-runs extraction for each period with period-end year from max(2023, current year − 2) through the current year, oldest first (up to three reporting years). This can take a long time.
Life-science tools—lab instruments, reagents, diagnostics, and biopharma services (Thermo Fisher).
Sector: Health care
US_TMO
No intraday sparkline from the default exchange feed; Yahoo or day change may still appear below when available.
No price chart.
Net debt (table and EV/EBITDA): |short-term borrowings| + |long-term borrowings| + |other financial liabilities| when extracted + |non-controlling interest| when extracted − |cash and equivalents|; amounts in millions of the reporting currency.
Shares: sec_companyfacts/97745
| Period | Issues |
|---|---|
| 2023-04-01 Q1 | ⚠Warn 1 |
| 2023-07-01 Q2 | ⚠Warn 1 |
| 2023-09-30 Q3 | ⚠Warn 1 |
| 2023-12-31 FY | ⚠Warn 1 |
| 2024-03-30 Q1 | ⚠Warn 1 |
| 2024-06-29 Q2 | ⚠Warn 2 |
| 2024-09-28 Q3 | ⚠Warn 1 |
| 2024-12-31 FY | ⚠Warn 1 |
| 2025-03-29 Q1 | ⚠Warn 1 |
| 2025-06-28 Q2 | ⚠Warn 2 |
| 2025-09-27 Q3 | ⚠Warn 1 |
| 2025-12-31 FY | ⚠Warn 1 |
| 2026-03-28 Q1 | ✗Errors 1Warn 1 |
Monetary columns are in B USD, one decimal; scale (K/M/B/T) keeps values readable. For the period (default) shows P&L and cash flow for that row’s reporting window: quarterly amounts when the feed uses quarter-duration facts (typical US 10-Q revenue and income), quarterly cash flows after stripping YTD where only cumulative tags exist, and an implied Q4 on 31 Dec FY rows (P&L: FY minus Q1–Q3; operating / investing cash flow: FY 12m minus 9M YTD to 30 Sep when sourced from SEC builder evidence) so they match 10-Q scale. Some issuers still use cumulative YTD minus the prior row in the same calendar year. As reported shows values stored on each row (e.g. full-year on FY). Balance sheet is always as reported. Source JSON may use millions etc.; conversion uses amounts_unit per row.
| Date | Period | Status | RevenueB USD | Operating profitB USD | D&AB USD | EBITDAB USD | Net profitB USD | Operating CFB USD | Capex + M&AB USD | AssetsB USD | EquityB USD | ROE (annualized) | Net debtB USD | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-28 | Q1 2026 (3M) | OK | 11.0 y/y 6.2% | 1.9 y/y 8.6% | 0.7 y/y 4.4% | 2.6 y/y 7.4% | 1.7 y/y 9.6% | 1.2 | -9.2 | 113.3 y/y 14.4% | 51.9 y/y 5.2% | 12.5% | 39.9 | Link |
| 2025-12-31 | FY 2025 (12M) | OK | 12.2 y/y 7.2% | 2.3 y/y 11.9% | 0.7 y/y -2.0% | 3.0 y/y 8.1% | 2.0 y/y 7.6% | 3.5 | -4.5 | 110.3 y/y 13.4% | 53.4 y/y 7.7% | 12.8% | 29.8 | Link |
| 2025-09-27 | Q3 2025 (3M) | OK | 11.1 y/y 4.9% | 1.9 y/y 5.6% | 0.7 y/y -10.5% | 2.6 y/y 1.0% | 1.6 y/y -0.9% | 2.2 | -0.4 | 103.0 y/y 2.6% | 51.0 y/y 4.1% | 4.2% | 33.7 | Link |
| 2025-06-28 | Q2 2025 (3M) | OK | 10.9 y/y 3.0% | 1.8 y/y 0.8% | 0.7 y/y -13.2% | 2.5 y/y -3.4% | 1.6 y/y 4.5% | 1.4 | -0.3 | 101.2 y/y 2.8% | 50.5 y/y 6.5% | 12.9% | 30.7 | Link |
| 2025-03-29 | Q1 2025 (3M) | OK | 10.4 y/y 0.2% | 1.7 y/y 3.2% | 0.7 y/y -15.7% | 2.4 y/y -3.1% | 1.5 y/y 13.2% | 0.7 | -0.4 | 99.0 y/y 2.0% | 49.4 y/y 8.5% | 12.2% | 30.1 | Link |
| 2024-12-31 | FY 2024 (12M) | OK | 11.4 y/y 4.7% | 2.0 y/y 8.7% | 0.7 y/y -11.6% | 2.8 y/y 2.4% | 1.8 y/y 10.9% | 3.3 | -3.6 | 97.3 y/y -1.4% | 49.6 y/y 6.1% | 12.9% | 27.5 | Link |
| 2024-09-28 | Q3 2024 (3M) | OK | 10.6 y/y 0.2% | 1.8 y/y -1.4% | 0.7 y/y -13.2% | 2.6 y/y -5.1% | 1.6 y/y -3.8% | 2.2 | -0.3 | 100.4 y/y 3.4% | 49.0 y/y 8.1% | 4.5% | 30.7 | Link |
| 2024-06-29 | Q2 2024 (3M) | OK | 10.5 y/y -1.4% | 1.8 y/y 15.3% | 0.8 y/y -7.6% | 2.6 y/y 7.3% | 1.5 y/y 13.7% | 2.0 | -0.3 | 98.5 y/y 4.7% | 47.4 y/y 8.4% | 13.3% | 28.3 | Link |
| 2024-03-30 | Q1 2024 (3M) | OK | 10.3 y/y -3.4% | 1.7 y/y 6.4% | 0.8 y/y -2.7% | 2.5 y/y 3.2% | 1.3 y/y 3.0% | 1.3 | -0.3 | 97.1 y/y 2.6% | 45.5 y/y 7.7% | 11.5% | 30.1 | Link |
| 2023-12-31 | FY 2023 (12M) | OK | 10.9 y/y — | 1.9 y/y — | 0.8 y/y — | 2.7 y/y — | 1.6 y/y — | 3.7 | -0.4 | 98.7 y/y — | 46.7 y/y — | 13.0% | 27.1 | Link |
| 2023-09-30 | Q3 2023 (3M) | OK | 10.6 y/y — | 1.9 y/y — | 0.9 y/y — | 2.7 y/y — | 1.7 y/y — | 2.4 | -1.2 | 97.1 y/y — | 45.3 y/y — | 5.1% | 29.1 | Link |
| 2023-07-01 | Q3 2023 (3M) | OK | 10.7 y/y — | 1.6 y/y — | 0.9 y/y — | 2.4 y/y — | 1.4 y/y — | 1.5 | -0.3 | 94.1 y/y — | 43.8 y/y — | 12.7% | 30.9 | Link |
| 2023-04-01 | Q2 2023 (3M) | OK | 10.7 y/y — | 1.6 y/y — | 0.9 y/y — | 2.4 y/y — | 1.3 y/y — | 0.7 | -3.2 | 94.7 y/y — | 42.3 y/y — | — | 31.8 | Link |
Quarterly values ($ mln)
Year-over-year change
Net debt / cash ($ mln)
Current 21.0x · 3-year average 22.8x
No dividend rows found for this issuer (checked: Yahoo Finance (ex-div)).
Reporting forms detected in loaded periods: ✓ ✓ ✓ (Balance sheet / Profit or loss (P&L) / Cash flows)